How to Run a Structured Off-Label Study for a Longevity Intervention Using Alethios

The longevity market moves fast. The evidence base often doesn't. This post covers how practitioners, researchers, and longevity innovators can use Alethios to run structured off-label observational studies — generating real-world data on compounds and protocols where formal clinical evidence is thin.

The longevity market operates in a particular kind of tension. Compounds like NMN, rapamycin, metformin, peptides, and GLP-1s are being used widely — often prescribed, purchased, or self-administered by people who have done serious research and made considered decisions — but the formal clinical evidence base for many of these uses lags significantly behind the pace of adoption.

Researchers and practitioners who work in this space know the situation: the interventions are real, the patients are real, and the data that exists is often either preclinical, observational without structure, or from populations that don't reflect the people actually using these compounds.

Alethios was built for exactly this gap.

What an Off-Label Longevity Study Looks Like

An off-label study on Alethios isn't a pharmaceutical trial. What it is: a structured, prospective observational study that follows participants who are already using (or beginning to use) a compound or protocol, collecting real-world data on outcomes, biomarkers, and experience over time.

This is meaningful for several reasons. It generates structured data where little currently exists. It allows you to study the actual population using these interventions — not a highly selected clinical trial population. And because it's structured from the start, the data is analyzable, shareable, and buildable upon.

Who This Is For

This approach is well suited for:

Longevity clinics and practitioners who are prescribing off-label and want to understand outcomes across their patient population in a more rigorous way
Independent investigators and researchers studying specific compounds or protocols
Supplement and nutraceutical companies with products in the longevity or healthy aging space who want real-world efficacy data
Academic researchers interested in naturalistic studies of longevity interventions

How to Design It

Define your intervention and population clearly. Are you studying a single compound, a stack, a protocol? Are participants new users or established ones? Clarity here determines what your data can actually tell you.

Choose endpoints that are sensitive to your intervention. The longevity space is rich in relevant measures: body composition, resting heart rate, HRV, sleep quality, step count, calories burned — all available as passive wearable endpoints in Alethios. For subjective outcomes, validated instruments for energy, cognition, and quality of life can be configured as survey endpoints. If you're collecting biomarkers externally (lab panels, at-home biomarker tests, continuous glucose monitoring, etc.), those can be incorporated as structured data inputs alongside Alethios-collected endpoints.

Think carefully about your observation window. Many longevity interventions have proposed mechanisms that operate over months, not weeks. Design your study duration to be long enough that you'd actually expect to see signal if it's there.

Use screening to define your population precisely. Longevity research often involves populations that are already health-engaged and self-directed. That's useful — but it also means your screening criteria should be explicit about what you're studying, so that your cohort is actually interpretable.

What Makes This Different From Just Tracking

Tracking is something many practitioners and self-experimenters already do. What structured research adds is the discipline that makes data meaningful: consistent measurement at defined time points, a pre-specified set of endpoints, and a record of who participated and why.

When you run a study on Alethios, you're not just collecting data — you're collecting it in a way that can be analyzed, reported, and used as the foundation for something more rigorous. That's the difference between notes and evidence.

Getting Started

Alethios studies can be configured and launched quickly, and the Study Planner is designed to make this accessible to teams that aren't clinical operations organizations. If you're a longevity practitioner, researcher, or innovator who's been thinking about generating more structured data on what you're doing, this is a practical place to start.

‍